Onyx Pharmaceuticals to Present at Merrill Lynch Conference
February 01 2007 - 3:00PM
PR Newswire (US)
EMERYVILLE, Calif., Feb. 1 /PRNewswire-FirstCall/ -- Onyx
Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will
present at the Merrill Lynch conference on Wednesday, February 7,
at 1:00 p.m. Eastern Time. Interested parties may access a live
webcast of the presentation at:
http://www.veracast.com/ml/pharma07/enter_MLX.cfm It is recommended
that listeners log on 15 minutes early in order to register and
download any necessary software. For those unable to participate
during the live webcast, a recorded replay of the presentation will
be available within 24 hours of the completion of the presentation
through March 7, 2007. Onyx Pharmaceuticals, Inc. is a
biopharmaceutical company developing innovative therapies that
target the molecular mechanisms that cause cancer. The company is
developing Nexavar(R), a small molecule drug, with Bayer
Pharmaceuticals Corporation. Nexavar has been approved for the
treatment of advanced kidney cancer. For more information about
Onyx's pipeline and activities, visit the company's web site at:
http://www.onyx-pharm.com/. NOTE: Nexavar(R) (sorafenib) tablets is
a registered trademark of Bayer Pharmaceuticals Corporation.
DATASOURCE: Onyx Pharmaceuticals, Inc. CONTACT: Alexandra Santos,
+1-510-597-6504 Web site: http://www.onyx-pharm.com/
Copyright
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Onyx Pharmaceuticals, Inc. (MM) (NASDAQ): 0 recent articles
More Onyx Pharmaceuticals (MM) News Articles